Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Year: 2013
Type: article
Source: Cancer Research
Institution: Takeda (Japan)
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: Takeda Pharmaceutical Company
OpenAlex ID: W1980427440
